about
Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesGenome-wide association studies identify four ER negative-specific breast cancer risk lociQuantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)Oestrogen exposure and breast cancer riskGenetic variation in the HSD17B1 gene and risk of prostate cancer.Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acidsDietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) studyFine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility lociCross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPhysical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort studyPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSA Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Genome-wide association study identifies multiple loci associated with bladder cancer riskGenome-wide association study identifies new prostate cancer susceptibility lociGenome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroupsGenome-wide association study identifies multiple risk loci for chronic lymphocytic leukemiaGenome-wide interaction study of smoking and bladder cancer riskSeven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyIdentification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.The INSIG2 rs7566605 polymorphism is not associated with body mass index and breast cancer risk.A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskCirculating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutritionPooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2.Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.
P50
Q23924183-ED77D54E-2DA4-4303-8AA5-ED966CB61DDEQ24170413-AEBBDC61-2840-4C5E-AA09-7A728CA4E4C7Q24622610-B635A150-5D69-4E51-9CFF-FD45277B2EA7Q24656179-A07DB215-B247-47F9-9FFF-E15BA21CD9DDQ24803498-0E4A2558-4A11-4F37-A7C3-FCA855F7B5B0Q24811147-7A2DA0FF-F81D-4324-9A4C-F266A20C31E0Q26256419-387C5DF8-6908-4BFE-BCF3-9495527EB56FQ27336054-F5CFF6F4-2CF4-4147-8294-84311F330FE9Q28248784-0A805E5E-64BF-483D-A06C-9D9AB78635F8Q28277313-79B2368B-3A4A-481F-944E-2224B471FE88Q28384269-70A20545-F842-41C9-A35E-2CFDB1223784Q28388475-B372B846-A22A-4AA2-9C93-0F98A1903879Q28388497-108DBD28-07EC-4027-AEE3-C3D883C7ECA1Q28391291-7138EF8B-A3B5-47DB-81F5-F1206AF068E9Q28584533-F0FB8FAA-BA35-43EB-8019-934ED824DFBBQ28601163-E937B3ED-D9FD-4B9A-A556-943810EABBC3Q28659283-6A7BE353-F889-496B-9478-2EC6C7723201Q28924380-FE7F64AA-65FD-4080-AABF-8ECD158F9A9FQ28943266-AE92C8E2-4BF2-4189-A183-E7C471B80D20Q28943339-E5B1BD12-EA56-4FA9-B00D-00844D5D953EQ28943359-1294590A-20BC-430D-871D-59D73E6D3783Q29417074-E907C026-1B81-47F6-AF76-A3BD8D30E86BQ29417155-33E5DAD4-B020-4D38-AD97-991BFC3D5F85Q30252854-8586076E-98DF-4EE1-812E-B8B248E462CBQ30977795-09FDB7C2-5192-4AF7-9A07-682A62BFF9C8Q30990502-0C1D18EE-7D04-479D-8F10-BE2D1A0CEEC8Q31049602-FAB23F18-3933-4714-8AE9-D64EA9A28101Q31072425-EBD4A263-ACBA-49FE-BBF1-1BFF4B2C5E56Q31112967-F8B52352-506D-4AC2-8A95-EE2686F605DDQ33348545-B5B45BA7-72E1-4944-973B-960A50F05608Q33616702-3CA951A6-24C9-4CC7-83F5-249B1C7D4F2DQ33716534-3B29DCC1-E128-4661-9F68-01666FC2C6B9Q33733210-ADC27420-3D1A-4D7C-AE57-ADD85551B463Q33835331-FE4FB431-F791-456B-9088-F02A57797761Q33836807-CB10BE5D-502B-456B-A645-F1B20D390E26Q33842251-C98D74B0-9C9D-4E9E-AD52-9B5364316AE7Q33845203-FDF046D3-E9E7-4C25-8115-6D3BF16224C3Q33845683-DA087998-BC13-4DC4-9C4E-32A54F731D60Q33872077-E6817A61-9ADA-4008-9069-2FD83F3DCC31Q33901167-37F91089-0244-4982-BE1C-4D1649ED83CF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ruth C Travis
@nl
Ruth Travis
@en
type
label
Ruth C Travis
@nl
Ruth Travis
@en
altLabel
Ruth C Travis
@en
prefLabel
Ruth C Travis
@nl
Ruth Travis
@en
P106
P21
P31
P496
0000-0002-9571-0763